AdreView (iobenguane I 123) Disease Interactions
There are 3 disease interactions with AdreView (iobenguane I 123):
Iobenguane I-123 (applies to AdreView) hypertension
Moderate Potential Hazard, Moderate plausibility.
Iobenguane I-123 may increase release of norepinephrine from chromaffin granules and produce a transient episode of hypertension. It is recommended to assess the patient's pulse and blood pressure before and intermittently for 30 minutes after iobenguane I-123 administration. Care should be exercised when using this agent in patients with hypertension. Prior to Iobenguane I-123 administration, ensure emergency cardiac and anti-hypertensive treatments are readily available.
Iobenguane I-123 (applies to AdreView) parkinson's disease
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Parkinsonism
Individuals with conditions that affect the sympathetic nervous system, e.g., Parkinsonian syndromes such as Parkinson's disease or multiple system atrophy, may show decreased cardiac uptake of iobenguane I-123 independent of heart disease.
Iobenguane I-123 (applies to AdreView) renal impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction
Iobenguane I-123 is cleared by the kidneys and is not dialyzable. When iobenguane I-123 is used in patients with severe renal impairment, the radiation dose may be increased due to delayed elimination of the drug which may also reduce the target to background rations and decrease the quality of scintigraphic images. Care should be exercised when using this agent in patients with severe renal impairment as the safety and efficacy have not been established in these patients. It is recommended to consider assessment of renal function in patients prior to iobenguane I-123 administration.
AdreView (iobenguane I 123) drug interactions
There are 78 drug interactions with AdreView (iobenguane I 123)
AdreView (iobenguane I 123) alcohol/food interactions
There is 1 alcohol/food interaction with AdreView (iobenguane I 123)
More about AdreView (iobenguane I 123)
- Side Effects
- Dosage Information
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: diagnostic radiopharmaceuticals
- FDA Approval History
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.